Approvals/TGA/Tezspire, tezepelumab 210 mg in 1.91mL solution for Injection prefilled pen

Approved

STANDARD

Tezspire, tezepelumab 210 mg in 1.91mL solution for Injection prefilled pen

AstraZeneca Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: d71a9b5801da9e7f
Product Name: Tezspire, tezepelumab 210 mg in 1.91mL solution for Injection prefilled pen
Artg Id: 432812
Artg Name: Tezspire tezepelumab 210 mg in 1.91mL solution for Injection prefilled pen
Sponsor: AstraZeneca Pty Ltd
Company Detail Path: /organization/astrazeneca-pty-ltd
Artg Date: 2025-03-24
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2025-CMI-01448-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2025-PI-01449-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

d71a9b5801da9e7f

Type

Standard